title: Nonthrombotic complications related to central vascular access devices.
abstract: Central vascular access devices (CVADs) provide reliable access for a variety of infusion therapies both in hospital and nonhospital settings. CVAD complications that are not identified and resolved can lead to a delay in therapy or the loss of vascular access. Rapid and accurate identification of complications is essential for obtaining expected treatment outcomes. This article will describe various nonthrombotic CVAD complications as well as identification and appropriate interventions used to manage these events.
authors.affiliation: Via Christi Health, Wichita, Kansas (Mr D. Ast); Baylor University Medical Center, Dallas, Texas (Dr T. Ast). Daniel Ast, MS, RN, CRNI®, has more than 30 years of experience in an acute health care environment. He has been in director, management, and staff positions, and has spent much of his career involved in intravenous therapy services at Via Christi Health. Mr. Ast is an educator and a coauthor of previous infusion-related publications. Travis Ast, PharmD, is a resident pharmacist at Baylor University Medical Center in Dallas, Texas.
authors.forename: Daniel
authors.initials: D
authors.lastname: Ast
authors.forename: Travis
authors.initials: T
authors.lastname: Ast
mesh_terms: D006801:Humans; D013927:Thrombosis / Q000209:etiology*; D062666:Vascular Access Devices / Q000009:adverse effects*